Richard Rosenfeld amp Richard Shiffman EGAPPS Breakout Session NY Academy of Medicine 1212 Standards for Developing Trustworthy Clinical Practice Guidelines Updated IOM Definition of Clinical Practice Guidelines ID: 930704
Download Presentation The PPT/PDF document "Making Guidelines Actionable" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Presentation Transcript
Slide1
Making GuidelinesActionable
Richard Rosenfeld & Richard Shiffman
E-GAPPS Breakout SessionNY Academy of Medicine 12/12
Slide2Standards for DevelopingTrustworthy Clinical Practice Guidelines
Updated IOM Definition ofClinical Practice Guidelines
Guidelines are statements that include recommendations intended to optimizepatient care that are informed by a systematic review of evidence and an assessment of the benefits and harms of alternative care options
http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust/Standards.aspx
Slide3AAO-HNS Clinical Practice Guideline Development Processwww.entnet.org
Slide4Clinical Practice Guideline Development: A Quality-Driven Approach for Translating Evidence into ActionPragmatic, transparent approach to creating guidelines for performance assessment
Evidence-based, multidisciplinary process leading to publication in 12-18 monthsEmphasizes a focused set of key action statements to promote quality improvement
Uses evidence profiles to summarize decisions and value judgments in recommendations
Rosenfeld & Shiffman, Otolaryngol HNS 2009
Otolaryngol Head Neck Surg 2009; 140(Suppl):S1-43
Slide5Two Approaches to Evidence and Guidelines
Evidence as Protagonist Model
Development is driven by the literature search,which takes center stage with exhaustive evidence tablesor textual discussions that rank and summarize citations.
Product is a Practice Parameter, Evidence
Report, or Evidence-Based Review
Evidence as Supporting Cast Model
Development is driven by a priori considerations of
quality improvement, using the literature search as one of many
factors that are used to translate evidence into action.
Product is a Guideline with Actionable Statements
Slide6Generating Topics for Action StatementsAsk “If we could only discuss a few aspects of this condition, what topics would we focus on most to improve quality of care?”
Ask “What should we focus on to minimize harm?”Consider high level evidence from systematic review and the concept list generating when discussion scope.
Remember: A quality-driven approach allows allimportant topics to be included, even if evidence isweak or limited. Action statements may still bepossible based on the balance of benefit and harm.
Rosenfeld & Shiffman, Otolaryngol HNS 2009
Developing key action statements begins with asking the group to suggest topics that are opportunities for quality improvement within the scope
Otolaryngol Head Neck Surg 2009; 140(Suppl):S1-43
Slide7Ranked Topic List for Hoarseness Guideline
Slide8Promote appropriate careReduce inappropriate or harmful care
Reduce variations in delivery of careImprove access to care
Facilitate ethical careEducate & empower clinicians & patientsFacilitate coordination & continuity of careImprove knowledge base across disciplinesQuality Improvement Opportunities
Eden J, Wheatley B, McNeil B, Sox H (eds).Washington, DC: Nat’l Academies Press
a.k.a. Potential topics for guideline action statements
Slide9Standards for DevelopingTrustworthy Clinical Practice Guidelines
Standard 6. Articulation of Recommendations6.1 Recommendations should be articulated in a standardized form detailing precisely: what the recommended action is, and under what circumstances it should be performed.
6.2 Strong recommendations should be worded so that compliance with the recommendation(s) can be evaluated.http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust/Standards.aspx
Slide10Statements of Fact vs. Action
Clinicians
should not routinely administer or prescribe perioperative antibiotics to children undergoing tonsillectomy.Antibiotic therapy does not improve recovery after tonsillectomy
The management of acute otitis externa
should include an assessment of pain
.
The clinician
should recommend analgesic treatment
based on the severity of pain.
Acute otitis externa (swimmer’s ear) is associated with moderate to severe pain.
Clinicians
should advocate for voice therapy
for patients diagnosed with hoarseness (dysphonia) that reduces voice-related quality of life.
Voice therapy has
been shown
to improve
quality
of life for patients with
hoarseness (dysphonia).
Clinicians
should use pneumatic otoscopy as the primary diagnostic method
for otitis media with effusion.
Pneumatic otoscopy is the most accurate test for otitis media with effusion.
Statement of Action
Statement of Fact
Slide11Guidelines ARE NOT Review Articles!
Guidelines contain key statements that are
action-oriented prescriptions of specific behavior from a clinician
Monitor
Test
Gather
Interpret
Perform
Dispose
Action
Conclude
Prescribe
Educate
Document
Procedure
Consult
Advocate
Prepare
Beware of the dreaded “Consider…”
Slide12Key Action Statements
An ideal action statement describes:When (under what conditions)
Who (specifically)Must, Should, or May(e.g., the level of obligation)do What (precisely)to Whom
Anatomy of a Guideline Recommendation
Action Statement Profiles andGuideline Development
Encourage an explicit and transparent approach to guideline writingForce guideline developers to discuss and document the decision making process
Create “organizational memory” to avoidre-discussing already agreed upon issuesAllow guideline users to rapidly understand how and why statements were developedFacilitate identifying aspects of guideline best suited to performance assessment
Key action statement with
recommendation strength
and justification
Supporting text for key
action statement
Action statement
profile:
Aggregate evidence quality
:
Confidence in evidence:
Benefit:
Risk, harm, cost:
Benefit-harm
assessment:
Value judgments:
Intentional vagueness:
Role of patient preferences
:
Differences of opinion:
Exclusions:
Slide15Diagnosis of acute rhinosinusitis: Clinicians should distinguish presumed acute bacterial rhinosinusitis (ABRS) from acute rhinosinusitis caused by viral upper respiratory infections and non-infectious conditions.
A clinician should diagnose ABRS when (a) symptoms or signs of acute rhinosinusitis are present 10 days or more beyond the onset of upper respiratory symptoms, or (b) symptoms or signs of acute rhinosinusitis worsen within 10 days after an initial improvement (double worsening). Strong recommendation based on diagnostic studies with minor limitations and a preponderance of benefit over harm.
AAO-HNS Adult Sinusitis Clinical Practice Guideline
Evidence profile (abbreviated):Aggregate evidence quality:
Grade B, diagnostic studies with minor limitations regarding signs and symptoms associated with ABRS
Benefits:
decrease inappropriate use of antibiotics for non-bacterial illness; distinguish non-infectious conditions from rhinosinusitis
Harms:
risk of misclassifying bacterial rhinosinusitis as viral, or vice-versa
Benefits-harm assessment:
preponderance of benefit over harms
Value judgments:
importance of avoiding inappropriate antibiotics for treatment of viral or non-bacterial illness; emphasis on clinical signs and symptoms for initial diagnosis; importance of avoiding unnecessary diagnostic tests
Otolaryngol Head Neck Surg 2007; 137(Suppl):S1-S31
Slide16Classifying Recommendations for Practice Guidelines
AAP Steering Committee on Quality Improvement and Management
Pediatrics 2004; 114:874-877
Slide17Action Statements as Behavior Constraints
MAY
SHOULD
MUST or SHOULD
Obligation level
Be flexible in decision making regarding appropriate practice, although bounds may be set on alternatives
Generally follow a recommendation, but remain alert to new information
Follow unless a clear and compelling rationale for alternative approach exists
Implication for clinicians
Option
Recommendation
Strong recommendation
Policy strength
Cross-sectional survey of 1,332 registrants of the 2008 annual AHRQ conference given a clinical scenario with recommendations and asked to rate the level of obligation they believe the authors intended
Lomotan
E, et al. How “should” we write guideline recommendations? Interpretation of deontic terminology. Quality Safety Health Care
2009
Slide18Slide19Slide20Standards for DevelopingTrustworthy Clinical Practice Guidelines
Standard 5. Recommendations
For each recommendation provide:An explanation of the reasoning including: benefits, harms, evidence summary (quality, quantity, consistency), and the role of values, opinion and experienceA rating of the level of confidence in (certainty regarding) the evidenceA rating of recommendation strengthA description and explanation of any
differences of opinion regarding the recommendation
http://www.iom.edu/Reports/2011/Clinical-Practice-Guidelines-We-Can-Trust/Standards.aspx
Slide21Building Better Guidelines with BRIDGE-Wiz
Description of a software assistant for structured action statement
creation to promote clarity, transparency and implementability
Shiffman
…Rosenfeld
et al, JAMIA 2012
J Am Med Inform Assoc
2012
; 19:94-101.
Choose an action type
Choose a verb
Define the object for the verb
Add actions
Check
executability
Define conditions for the action
Check decidability
Describe benefits, risks, harms & costs
Judge the benefit-harms balance
Select aggregate evidence quality
Review proposed strength of recommendation and level of obligation
Define the actor
Choose recommendation style
Edit the final statement
Slide22Testing for allergy and immune function: Clinicians may obtain testing for allergy and immune function in evaluation a patient with chronic rhinosinusitis (CRS) or recurrent acute rhinosinusitis.
Option based on observational studies with an unclear balance of benefit vs. harm.AAO-HNS Adult Sinusitis Clinical Practice Guideline
Evidence profile:
Aggregate evidence quality: Grade C, observational studies
Benefits:
identify allergies or immunodeficient states that are potential modifying factors for CRS or recurrent acute rhinosinusitis
Harms:
procedural discomfort; instituting therapy based on test results with limited evidence of efficacy for CRS or recurrent acute rhinosinusitis; very rare chance of anaphylactic reactions during allergy testing
Cost:
procedural and laboratory cost
Benefits-harm assessment:
unclear balance of benefit vs. harm
Value judgments:
need to balance detecting allergy in a population with high prevalence vs. limited evidence showing benefits of allergy management outcomes
Role of patient preferences:
role for shared decision making
Otolaryngol Head Neck Surg 2007; 137(Suppl):S1-S31
Slide23Classifying Recommendations for Practice Guidelines
AAP Steering Committee on Quality Improvement and Management
Pediatrics 2004; 114:874-877
Slide24Clinicians and OptionsEvidence quality is suspect or well-designed studies have demonstrated little clear advantage to one approach vs. another
Options offer flexibility in decision making about appropriate practice, although they may set boundaries on alternativesHard to hold clinicians accountable (performance measures)Patient preference should have a substantial role in influencing clinical decision making
What Do They Mean?
Slide25Slide26…And Now It’s Your Turn…
Slide27Treatment & Prevention of the Common Cold
Cochrane Systematic Reviews
The Cochrane Library, 2010; John Wiley & Sons, LtdIntervention (update)
Evidence
Conclusion
Antibiotics (2009)
6 trials
No benefits; more adverse events
Non-steroidal anti-inflammatory drugs (2009)
9 trials
Reduced headache, ear pain, muscle & joint pain; no effect on duration or adverse events
Echinacea (2007)
16 trials
Some early treatment benefit; no effect on prevention
Heated, humidified air (2006)
6 trials
Benefit for symptom relief in 3 studies; overall effects equivocal; minor discomfort, irritation, congestion
Chinese medicinal herbs (2008)
17 trials
Faster recovery 7 trials; no benefits in 10; problem with heterogeneity
Vitamin C (2010)
29 trials
Reduced duration and severity in prophylaxis trials (but not treatment trials); no benefit for prevention
Garlic (2009)
1 trial
Benefit for prevention in a single trial